Clinical Trial Detail

NCT ID NCT04004442
Title Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma (COAXIN)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Oklahoma
Indications

urethra transitional cell carcinoma

ureter transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

Therapies

AVB-S6-500 + Avelumab

Age Groups: adult senior

No variant requirements are available.